149 related articles for article (PubMed ID: 30191557)
1. Cytomegalovirus ulcers following radiotherapy for a Marjolin ulcer in a renal transplant recipient.
Wang CY; Mulley WR; Dendle C; Mar A
Australas J Dermatol; 2019 May; 60(2):e145-e147. PubMed ID: 30191557
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
[TBL] [Abstract][Full Text] [Related]
3. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
Saghafi H; Qorashi M; Heidari A
Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus-induced adrenal insufficiency in a renal transplant recipient.
Ardalan M; Shoja MM
Transplant Proc; 2009 Sep; 41(7):2915-6. PubMed ID: 19765472
[TBL] [Abstract][Full Text] [Related]
5. Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre.
Gupta E; Pamecha V; Verma Y; Kumar N; Rastogi A; Hasnian N; Bhadoria AS
Indian J Med Microbiol; 2017; 35(4):499-503. PubMed ID: 29405140
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
[TBL] [Abstract][Full Text] [Related]
7. Skin Leg Ulcer in an Immunocompromised Patient With Pseudomonas aeruginosa Sepsis. Cytomegalovirus ulcer.
Lloret-Ruiz C; Moles-Poveda P; Terradez-Raro JJ
JAMA Dermatol; 2015 Jun; 151(6):661-2. PubMed ID: 25714453
[No Abstract] [Full Text] [Related]
8. Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia.
Sénéchal M; Dorent R; du Montcel ST; Fillet AM; Ghossoub JJ; Dubois M; Pavie A; Gandjbakhch I
Clin Transplant; 2003 Oct; 17(5):423-7. PubMed ID: 14703924
[TBL] [Abstract][Full Text] [Related]
9. Donated organs as a source of cytomegalovirus (CMV) in renal transplant patients.
Costa SC; Miranda SR; Alves G; Rossi CL; Figueiredo LT; Costa FF
Braz J Med Biol Res; 1994 Nov; 27(11):2573-8. PubMed ID: 7549979
[TBL] [Abstract][Full Text] [Related]
10. Locally produced specific cytomegalovirus immunoglobulin for intramuscular use as a therapy in renal allograft recipients.
Trkuljić M; Ignjatović L; Hrvacević R; Taseski J; Dujić A; Jovanović D; Kuljić-Kapulica N
Vojnosanit Pregl; 2001; 58(2):131-6. PubMed ID: 11475664
[TBL] [Abstract][Full Text] [Related]
11. Postural epigastric pain as a sign of cytomegalovirus gastritis in renal transplant recipients: a case-based review.
Li W; Fan H; Yiping L
Transplant Proc; 2009 Nov; 41(9):3956-8. PubMed ID: 19917423
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus Scrotal Ulcer in a Renal Transplant Patient.
Pinca R; Crawford RI; Au S
J Cutan Med Surg; 2016 Nov; 20(6):567-569. PubMed ID: 27207356
[TBL] [Abstract][Full Text] [Related]
13. [Cytomegalovirus infection in peptic ulcer in renal transplant recipient: a case report].
Ishiguro S; Ikeda T; Shimamoto K; Tanji N; Ohoka H; Yokoyama M
Nihon Hinyokika Gakkai Zasshi; 2004 Sep; 95(6):777-80. PubMed ID: 15508703
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection in the first year after pediatric kidney transplantation.
Tanné C; Roy P; Frobert É; Duncan A; Laurent A; Cochat P
Nephrol Ther; 2019 Mar; 15(1):44-50. PubMed ID: 29887270
[TBL] [Abstract][Full Text] [Related]
15. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
Lochmanova A; Lochman I; Tomaskova H; Marsalkova P; Raszka J; Mrazek J; Dedochova J; Martinek A; Brozmanova H; Grundmann M
Transplant Proc; 2010 Nov; 42(9):3574-7. PubMed ID: 21094818
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous cytomegalovirus - A case of disseminated cytomegalovirus presenting with extensive ulcerative skin lesions in a renal transplant recipient.
Ferguson J; Mooney K; Saleem A; Stevens BA; Pinsky BA; Centkowski S; Zaba LC; Ho DY
Transpl Infect Dis; 2021 Aug; 23(4):e13582. PubMed ID: 33533137
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.
Hibberd PL; Tolkoff-Rubin NE; Cosimi AB; Schooley RT; Isaacson D; Doran M; Delvecchio A; Delmonico FL; Auchincloss H; Rubin RH
Transplantation; 1992 Jan; 53(1):68-72. PubMed ID: 1310173
[TBL] [Abstract][Full Text] [Related]
19. Impact of OKT3 and polyclonal antibodies on symptomatic CMV infection in renal transplant recipients.
Yeung S; Tong KL; Chan HW
Transplant Proc; 2000 Nov; 32(7):1928-9. PubMed ID: 11120005
[No Abstract] [Full Text] [Related]
20. Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience.
Favi E; Santangelo R; Iesari S; Morandi M; Marcovecchio GE; Trecarichi EM; Salerno MP; Ferraresso M; Citterio F; Romagnoli J
Transplant Proc; 2017 Oct; 49(8):1766-1772. PubMed ID: 28923622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
